AZACITIDINE
BLU-263-2101
Phase 2 small_molecule active
Quick answer
AZACITIDINE for Advanced Systemic Mastocytosis is a Phase 2 program (small_molecule) at Blueprint Medicines (Netherlands) B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Blueprint Medicines (Netherlands) B.V.
- Indication
- Advanced Systemic Mastocytosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active